Region-based genome-wide scans are usually performed by use of a priori chosen analysis 27 regions. Such an approach will likely miss the region comprising the strongest signal and, 28 thus, may result in increased type II error rates and decreased power. Here, we propose a 29 genomic exhaustive scan approach that analyzes all possible subsequences and does not rely 30 on a prior definition of the analysis regions. As a prime instance, we present a 31 computationally ultra-efficient implementation using the rare-variant collapsing test for 32 phenotypic association, the genomic exhaustive collapsing scan (GECS). Our implementation 33 allows for the identification of regions comprising the strongest signals in large, genome-wide 34 rare-variant association studies while controlling the family-wise error rate via permutation. 35
Introduction 40
Genomic scans assess genomic regions (usually subsequences) with respect to some statistical 41 measure and, ideally, quantify its consistency with the null hypothesis. Prominent applications 42 include the detection of allele frequency differences between cases and controls in genetic 43 association studies (CHRISTOPHERSEN et al. 2017) , the departure of the site-frequency 44 spectrum (SFS) from the expectation under neutral evolution in selection analysis (NIELSEN et 45 al. 2005 ) and of differential methylation patterns in epigenomics (JAFFE et al. 2012) . 46
Although statistical tests differ, the basic procedure remains similar across these applications 47 by comprising (1) the prior definition of a set of contiguous analysis regions (bins) B ij , 48 characterized by start positions i and end positions j ("binning"), sometimes defined by setting 49 scanning parameter values ("sliding window"); (2) the calculation of a suitable summary or 50 test statistic, T(B ij ), for each bin; (3) the distributional assessment of the statistics in order to 51 identify extreme values, frequently including the calculation of p-values, and often, but not 52 always, followed by control of the family-wise error rate (FWER). 53
With long chromosomal sequences, it is not known in advance which subset of possible 54 subsequences is most suitable for statistical summarization and testing, i.e. which regions will 55 provide the highest power. Use of a priori fixed regions, including sliding-window approaches 56 with fixed bins, will result in a highly likely increase in the type II error rate and, 57 correspondingly, reduced power, because regions comprising the strongest signal(s) will 58 almost certainly not be chosen prior to the analysis. A more probable scenario is that a region 59 of interest will only partially coincide with the chosen analysis region. As a consequence, the 60 signal will be diluted by inclusion of non-relevant variants, split across multiple analysis 61 regions, or both. Fixed, pre-determined binning therefore represents a major limitation of 62 current genomic scans. Moreover, due to unknown correlation structures between regions, the 63 correction for multiple testing is often performed in a conservative way, e.g. by use of 4 Here, we focus on the application of the exhaustive scan approach to rare-variant (RV) 66 association studies based on sequenced or genotyped data. RV analysis is motivated by the 67 observation that, although genome-wide association studies (GWAS) have usually identified 68 common risk alleles for a wide range of complex diseases (MANOLIO et al. 2009 ), most of 69 these alleles cause at most moderate increases in risk and contribute little to the overall 70 heritability of diseases individually, leaving large portions of human diseases' heritability 71 unexplained (FELDMAN and RAMACHANDRAN 2018; MANOLIO et al. 2009 ). This observation 72 motivated studies to focus on the role of RVs, aiming to deliver functionally interpretable 73 variants of moderate to large effect sizes and explaining additional disease risk variability. have similar effects on the phenotype. Under this assumption, multiple RVs in a genomic 80 region can be aggregated and analyzed as a unit. In this context, the most common approach is 81 to define fixed bins by either using the locations of known protein-coding genes as regions of 82 analysis or by using a sliding-window approach with two fixed parameters, namely the 83 window size and the step size. Either choice is fundamentally limited in scope, and will 84 consider only a tiny fraction of possible subsequences. 85
In RV analysis, "rareness" itself is another parameter that is usually defined by a threshold of 86 the minor allele frequency, MAF T. Alternatively, weighting schemes have been proposed that 87 assign lower weights to variants with higher allele counts. This does not fully solve the 88 problem of rareness thresholds, as the shape of the weighting function is usually chosen 89 somewhat arbitrarily and without a stringent justification of its usefulness. 90
Noteworthy progress towards non-parametric RV analysis has been made in (PRICE et al. 91 5 possible MAF T are computed and the optimal MAF T is adapted from the data. The method 93 uses permutation testing to adjust for the large number of tested hypotheses within a bin; it is 94 therefore computationally more intense. In (DRICHEL et al. 2014 Here, we propose the use of exhaustive scans to all possible contiguous subsequences and to 116 perform multiple-testing correction by obtaining the distribution of extreme p-values from 117 replicates of the data simulated under the null hypothesis by repeatedly permuting case-118 control status. We introduce this approach, in an exemplary way, for a specific application, 119 namely the genomic exhaustive collapsing scan (GECS) approach for COLL, and present a 120 computationally efficient implementation of GECS. We show that, although the number of 121 possible contiguous bins for all RVs at a single chromosome is very large, namely n(n+1)/2 122 with n variants, the number of distinct bins dramatically reduces by about 3 to 4 orders of 123 magnitude, rendering GECS feasible and scalable even for whole-genome sequence data in 124 large sample sets. Furthermore, this acceleration allows control of the family-wise error rate 125
The combined (adjusted for testing at the different MAF T ) significance thresholds ranged 139 between 7.35×10 -10 and 2.59×10 -10 for N=1,000 and N=20,000, respectively. 140
In real-world data, the combined significance thresholds were 1.87×10 -8 for the exome dataset 141 (SCZD) and 1.43×10 -9 for the imputed data (AAMD). The much higher, and therefore less 142 stringent, thresholds were expected due to the incomplete genomic coverage of the available 143 real data. It is expected that in whole-genome, deeply sequenced studies the significance 144 thresholds will be closer to the results obtained in the simulated data (Table 1) . 145
We evaluated the statistical power of GECS, also in comparison to SMA, by simulating 146 realistic case-control sequence data of 2.5-100kb regions under a variety of disease etiology 147 models and sample sizes (Table S1 ). The exhaustive scan was applied to the simulated region 148 and the significance of the strongest signal was determined using the global significance 149 thresholds (Table 1) . Here, we focus on results for PNV=0.3 since results for the different 150 proportions of considered neutral variants (PNV) were similar. 151
Power in models of rare diseases. In small (N=1,000) case-control association studies of 152 diseases with low prevalence (K=0.01), GECS performed substantially better than SMA 153 across all considered inheritance modes in the presence of moderate to large proportions of 154 detrimental rare variants (PDV) ( Figure 2 ). In particular, the power ranged between 80% and 155 99% for high ORs (15≤OR≤ 25) with PDV≥0.3, whereas SMA's power reached at most 40%. For moderate sample sizes (N=10,000), both methods provided comparable power, although 164 of the performance of GECS was clearly superior for small to medium OR and PDV>0.1 165 ( Figure 3 ). For PDV=0.1, the SMA kept a slight advantage over GECS, although it was much 166 less pronounced than in small-sample studies (N=1,000). A similar observation was made in 167 studies with large sample size (N=20,000): power of both methods were higher for small OR 168 values, but GECS remained much more powerful than SMA with moderate to large PDV 169 values; only low proportions of detrimental rare variants favored the SMA ( Figure S5 ). 170
Increasing PDV always resulted in a power increase for GECS, while SMA remained 171 underpowered (<50% for N=1,000 and 10,000) for small OR values even for the highest 172 proportion of detrimental rare variants (PDV=0.9). 173
The impact of the assumed inheritance mode was broadly similar for the dominance (DOM), 174 additive (ADD) and multiplicative (MULTI) genotypic inheritance modes, whereas the 175 recessive mode (REC) resulted in the lowest power values for both GECS and SMA. The 176 difference reached up to 40% for studies with small OR values (< 3). This is not surprising 177 since homozygous carriers of rare variants are expected to be very rare. Extreme PDV values 178 resulted in highly similar power values of about 10% (PDV=0.1) and about 100% (PDV=0.9) 179 for all four modes, while intermediate values, ranging between 0.3 and 0.7, resulted in more 180 pronounced differences between the recessive mode and the other three modes. 181
Power in models of common diseases. Applying GECS and SMA to diseases of higher 182 prevalence (K=0.1) yielded some similarities to the results for rare diseases (K=0.01), but also 183 some marked differences. In general, the power of both approaches slightly decreased. 184
Differences between the two prevalence classes where most pronounced for small sample 185 sizes (N=1,000) and a recessive inheritance mode (detailed results are shown in 186 Supplementary Note (e)). 187
Real-data analysis
188
Advanced age-related macular degeneration (AAMD) 189
We applied GECS to the whole-genome imputed case-control data of the subset of samples 190 with European ancestry and cases with AAMD from the international AMD genomics 191 consortium (Table S2 -3). The analysis was conducted for three MAF thresholds, and the 192 genome-wide significance threshold in the combined study equaled 1.43×10 -09 (Table 2, 193 Figures S13-16). Previously, strong signals were found in genetic regions on chromosomes 1, 194 3, 4, 6, 19 and 22, mostly from common variants (Table S7, Figure S13 ). Recently, 16 other 195 regions containing significant association signals with rare variants were reported (FRITSCHE 196 et al. 2016) (Table S8 ). GECS identified more than 100 genomic regions on chromosomes 1, 197 3, 4, 5, 6, 10 and 19, where bins of rare variants were found to be significantly associated with 198 AAMD (locally validated by SKAT) (Tables 3, S9 ). The strongest signals were detected in 199 bins overlapping with protein-coding genes, including HLA-B, HLA-DRA, and MICB in 200 chromosome 6, FYB in chromosome 5, CFD, and NRTN in chromosome 9, and PLEKHA1 in 201 chromosome 10 (Table S10 ). These genes, among others, are involved in the regulation of the 202 immune system process and innate immune response). The set of genes overlapping 203 significant bins were enriched in the activation of immune response pathway, in particular, the 204 positive regulation of immune response (7.36-fold enrichment, Bonferroni-corrected p-value 205 of 4.4×10 -4 ; a complete list of gene ontology results are shown in Table S11 ). Additionally, 206 GECS re-identified and re-find most of the previously reported rare variant associations with 207 AAMD (e.g. CFI, C3, SKIV2L, SYN3, and C9) ( (Table S12 ). Odds ratios of identified bins ranged between 0.5 and 3.45, indicating that carrier 209 status can be both positively and negatively correlated with AAMD. However, significant bins 210 with OR>1 were overrepresented on chromosome 6, with OR values ranging between 1.1 and 211 1.4 and bin sizes ranging between 2 and 26 rare variants. 212
Notably, bin 6.I (chr6:31,323,455-31,323,745bp, hg19) of 12 rare variants (MAF≤0.05) was 213 found to be significant with a p-value of 3.48×10 -11 , p' -value of 2.76×10 -10 and OR of 1.
214
This bin overlaps with the protein coding human leukocyte antigen B (HLA-B), which plays a 215 very important role in the immune system ( Figure S17 ). Interestingly, a previous study found 216 a positive correlation between the HLA-B allele HLA-B27 with AAMD (VILLEGAS BECERRIL 217 et al. 2009). Also, bin 6.II (chr6:31,473,707-31,474,883bp) overlapped with the MICB gene 218 and comprised 6 rare variants (MAF≤0.05). This bin was found to be significantly associated 219 with AAMD with p-value 1.71×10 -10 , p'-value of 2.08×10 -13 and OR=1.3 ( Figure S18 ). An 220 example for a bin with OR<1 is 10.I (chr10: 124,226,492-124,249,185bp), which comprised 221 64 rare variants (MAF≤0.05), was found to be associated with AAMD with p-value of 222 2.09×10 -84 , p'-value of 2.96×10 -30 with OR=0.6. Notably, this bin, with an apparently 223 protective effect of rare alleles overlaps with HTRA1, which has been functionally studied in 224 the context of AMD (NG et al. 2012 ). The association signal was independent from multiple 225 common variants found to be associated with AAMD in this gene 226 MCKIBBIN et al. 2012 ). Another noteworthy finding was bin 6.IV (chr6: 31,878,006 -227 31,878,721bp) with 5 rare variants in the C2 gene (MAF≤0.05) was found to be significantly 228 associated with AMD with p-value 3.78×10 -80 , p'-value 1.23×10 -70 , but with OR=0.5 (Figure 229 S19). Our finding is in line with the known role of some protective haplotypes in the C2-AS1 230 region were found to be significantly reducing the risk of AMD (GOLD et al. 2006 ). For more 231 results see Supplementary Note (f). 232
Schizophrenia 233
Gene-disruptive and putatively protein-damaging rare variants have been found to be enriched 234 (Table S5 ). The analysis was conducted for three MAF thresholds, and the genome-237 wide significance threshold in the combined study comprised 1.87×10 -08 ( was found to be significant, with p-value 2.59×10 -09 , p'-value 3.11×10 -10 and OR=1.3, 247 covering exonic regions of the MUC16 gene ( Figure S25 ). Although some rare alleles in 248 MUC16 were reported in association to schizophrenia, none of the 62 rare alleles in this bin 249 were reported before. Moreover, genes covered by bins 15.I, 17.I, 19.I, and 22.I were found to 250 have a function in the small molecule metabolic processes. Interestingly, gene PRSS3 was 251 covered by bin 9.I (9:33,796,672-33,798,630) comprising 20 rare variants (MAF≤0.05), p'-252 value of 3.89×10 -11 and OR=1.4. This gene was not previously reported to be related to 253 schizophrenia. The relatively small sizes of the detected significant bins in the WES data of 254 schizophrenia indicate that the availability of large whole-genome sequencing studies will 255 enable a considerable power gain for our method (Table S17) . 256
Benchmarking of GECS for real-world data sets. GECS was found to be feasible for large 257 data sets (Table 18 ). Analyzing the imputed whole-genome data of AMD, comprising 27,259 258 samples and round 900,000 variants, took less than 4 hours when analyzing each chromosome 259 in parallel. On average, GECS required fewer computational resources than SMA, with 260 memory usage ranging between 1-5 GB for GECS and about 14 GB for SMA (Table S19) . 261
The analysis of the schizophrenia WES data (~10,000 samples, ~300,000 SNPs) took at 262 maximum 14h for GECS and 6 h for SMA (Table S19 ) (for more details see Supplementary 263
Note (g)). 264
Discussion

265
While genome-wide scans with heuristically predetermined analysis regions are an established 266 approach, they are limited in their scope, resolution and power by requiring a prior choice of 267 the analysis regions. In the context of selection analysis, Akey fittingly compared the scan to a 268 hatchet and called for more refined scalpel-like approaches (AKEY 2009). We argue that in 269
Akey's analogy, the exhaustive scan is an electron microscope, as it allows for base-pair level 270 analysis of genomic regions, with genome-wide, non-conservative, optimally powerful 271 correction for multiple testing using replicates of the data generated under the null hypothesis. 272
GECS is scalable to large association studies of imputed and sequenced variant data, as 273 demonstrated by our simulation of the null model. The efficiency of our implementation 274 allowed us to estimate significance thresholds for rare-variant analysis in whole-genome 275 sequenced data for association studies comprising up to 20,000 individuals. As a by-product, 276 the analysis offered another opportunity to study significance thresholds (FWER control at 277 5%) for single-marker analysis (SMA), which, even for small sample sizes of N=1,000 was 278 found to be stricter (α=2.95 ×10 -8 ) than the commonly used threshold of α=5. and highlights the need to abandon the "agreed-upon" significance threshold of 5.0×10 -8 , 281
which is anticonservative for large-scale association studies. 282
As expected, we found the region-based collapsing test to have stricter significance levels 283 than SMA, ranging between α=3.61×10 -9 and α=1.60×10 -9 on average for N=1,000 and MAF T 284 equaling 0.01 and 0.05, respectively, which corresponds to 13.9-31.2 million independent 285 tested hypotheses. These estimates of α allow us to assess the absolute power of the region-286 based exhaustive scan in future whole-genome deeply sequenced data sets. In contrast to 287 previous studies (ZAWISTOWSKI et al. 2010), the power study is free from the assumption that 288 the simulated region and the analysis region happen to coincide. Since the exhaustive scan is 289 guaranteed to identify the most strongly associated regions, our FWER control accounts for 290 the multiple-testing "cost" of finding these regions, which was ignored in previous studies. 291
Overall, the power of GECS is higher, or at least comparable to SMA for small to moderate 292 odds ratios of associated rare variants (1.01≤OR<3), being the OR range expected to be most 293 commonly found in complex diseases. For large sample sizes and large effect sizes, GECS, in 294 general, offers no advantage to detect association. This result reflects the expectation that 295 given a large sample size, enough rare alleles will be present to detect associated variants with 296 sufficient power in single-variant tests (AUER and LEAL 2017). 297
We applied GECS to real-world data sets, namely of AAMD (imputed microarray data) and 298 of schizophrenia (WES), and performed very stringent quality control of both sets to avoid 299 possible type I errors. Application of GECS to AAMD confirmed a multitude of previously 300 reported rare associated SNPs, for which SMA was underpowered to pick up many signals 301 due to the low MAFs. We confirmed that exhaustively scanning for association through all 302 possible combinations of contiguous rare variants from different MAF thresholds alleviates 303 the limitations posed by previous fixed-bin strategies. The in-depth follow-up analysis showed 304 high enrichment of genes covered by identified bins in pathways with key roles in the 305 development and function of immune system. This is consistent with previous findings, as a 306 putative role for the immune system in the pathogenesis of AMD has been suggested since the 307 1980s (NUSSENBLATT et al. 2014 ). Furthermore, a locally exhaustive analysis with SKAT 308 uncovered some bins with more extreme p-values than those detected by GECS, such as in bin 309 4.I. This is expected, since GECS considers the carrier status only and therefore has a low 310 "resolution" in the space of allele counts. SKAT, however, is sensitive to the allele counts, so 311 that bins that have identical contingency tables in GECS test can have differing association 312 testing results with SKAT. On the other hand, a truly exhaustive SKAT analysis is 313 computationally not feasible, so that GECS is required for identification of regions that can be 314 followed up with SKAT locally. 315
Our approach was also successfully applied to the schizophrenia data set, uncovering 316 previously unreported associations, notably with the PRSS3 gene. However, judging by the 317 limited spatial extent of the resulting bins, the approach might be underpowered due to limited 318 coverage of the genome in WES studies and will probably improve with availability of WGS 319 data. 320
In summary, GECS is a powerful approach for detecting phenotypic association of genomic 321 regions harboring rare variants and for refining our understanding of their contribution to 322 predisposition for complex diseases. We conclude that our approach is well-suited for whole-323 genome and whole-exome association analyses. However, GECS utilizes the simple allele 324 counting function of COLL to achieve perfect, essentially base pair-level spatial resolution. 325
As COLL is only able do dichotomize individuals by the carrier status, the test is not able to 326 distinguish between carriers of one or more minor alleles. We alleviated the limitations of 14 COLL by performing follow-up analysis of candidate regions with locally exhaustive scans 328 using SKAT. However, enabling the exhaustive scan with more sophisticated tests that take 329 more sources of information into account, like allele counts and covariates, might reveal 330 further associated candidate regions. The challenge of extending the exhaustive scan approach 331 to more complex association tests is purely computational in nature. Our algorithm does not 332 generalize to other published association tests in a straightforward manner, so that new 333 solutions will be required to generalizing the exhaustive association scan beyond the 334 collapsing method. 335
Application of exhaustive scans is not limited to association testing and could be useful in 336 further applications, in particular for studying methylation and evolutionary selection. In fact, 337 our preliminary results show that the exhaustive scan is feasible for the study of selection 338 when used with site frequency spectrum (SFS) based tests such as Tajima's D (data not 339 shown). This is due to the fact that the computational complexity of SFS-based tests is 340 independent from the number of individuals in the study, since only allele count data is 341 required. As a consequence, the quadratic space of all contingent regions can be computed by Supplementary Note (a) ).The test only considers those 359 variants whose minor allele frequency is below a pre-determined threshold (MAF T ).We 360 propose an exhaustive region-agnostic whole-genome scan approach that avoids pre-361 determination (and probable misspecification) of bins by considering all possible contiguous 362 regions at a chromosome. The computational burden, usually prohibitive with human and 363 other large genomes, is solved for COLL by identifying overlapping bins that are identical 364 with respect to their variant carrier status in cases and controls, and skipping redundant 365 computations. More specifically, consider a study with n variants with MAF less or equal to a 366 fixed MAF T being present at a chromosome. When conducting COLL, we can parameterize 367 the data set using binary arrays 1 , 2 , … , , each of length N, where N denotes number of 368 samples and the elements , indicate the carrier status of the l-th individual (1=carrier, 369 0=non-carrier) at the i-th variant. Since the analyzed variants are rare, the arrays are sparse 370 (most entries equal 0). We note that, although MAF T is usually used to define "rareness", in 371 the setting of COLL, we use the number of carriers , as COLL does not distinguish 372 between homozygous and heterozygous rare-allele carries. By using the cutoff , we define 373 a fixed maximum count of 1's in the arrays . properties of the logical OR operation that allow to perform early abandoning of a row while 405 being sure that no distinct bin will be missed in the non-computed elements of the matrix. The 406 crucial observation is that early abandoning can be performed if a bin is equal to ( +1) , 407
i.e. the exact element below in the matrix. The condition = ( +1) ensures that ( + ) = 408 ( +1)( + ) for all k ≥ 0. In other words, if the condition is encountered once, it will be 409 satisfied for the remainder of the row, which is a direct consequence of OR operator's truth 410 table. Intuitively, if the minor allele of the start variant v i is not carried by any individual that 411 does not already carry at least one minor allele in ( +1) , then v i will not contribute any new 412 carriers to bins with an incremented end position ( j+k ). Therefore, all distinct bins not yet 413 encountered in row i will be encountered in the next row, and may be in the following rows. 414
This observation allows eliminating redundant computations inductively. Early abandoning 415
can also be performed if a bin is found in which all individuals are carriers, i.e. the encoding 416 binary array consists of only 1's, = , since the array remains "fully collapsed" for the 417 remainder of the row. In pseudocode, the algorithm can be summarized as follows (see 418 Supplementary Note (b) for comprehensive example of the algorithm and its implementation). 419
We implemented this algorithm in our publicly available analysis software GECS 421 (https://github.com/ddrichel/GECS) using C++. 422
Finally, we note that although we perform our analysis under either one or multiple fixed 423 thresholds , it is possible to generalize the algorithm to consider all possible thresholds , 424
i.e. to simultaneously perform a variable threshold (VT) analysis (see Supplementary Note 425 (c)). However, the algorithm of GECS combined with VT approach is in general not efficient 426 enough to handle large-scale association studies. We therefore resort to applying GECS with 427 three fixed . Control of the FWER can be performed by combining the results from the 428 three separate permutation runs under different MAF T s (see Supplementary Note (d) ). 429
Following (KULLDORFF 1997), we aim to perform at least 9999 permutation replicates for 430 significance testing at alpha=0.05, however for large data sets we sometimes only use 999 431
permutations. 432
Genome-wide significance thresholds for rare-variant analysis 433 The analysis of large genomic data sets involves simultaneous testing of many hypotheses, 434 whose dependency structure may be unknown. Population history is a strong determining 435 factor for this structure, as it induces specific patterns of genetic variation and allelic 436 correlation. A genome-wide significance level α for analyzing rare variants in genomic data to 437 control type I error will depend on the studied data set and the used statistical test. Given that 438 the number of rare variants is high and that the number of possible bins grows quadratically 439 with the number or rare variants, it can be expected that an exhaustive analysis of all possible 440 contiguous subsequences will require smaller α than with tests of single common variants. For 441 single-marker analysis, the problem of determining significance thresholds that control the 442 FWER has been approached analytically (DICKHAUS and STANGE 2013) and by using Monte-443 Carlo (MC) simulations (PULIT et al. 2017). In realistic scenarios, the analytical approach has 444 to rely on approximations, possibly resulting in a conservative bias. On the other hand, the 445 MC approach results in a quickly converging approximation of the exact thresholds, under the 446 condition that the computational burden can be overcome (ATANASSOV and DIMOV 2008). In 447 this study, we used the maxT/minP approach by (WESTFALL P. H. 1993) in order to control 448 the FWER at the 5% level, performing 999 permutations with respect to the case-control 449 labels. When conducting an analysis with multiple MAF T , maxT/minP is obtained across 450 MAF T levels in each permutation, subsequently determining the combined significance level. 451
This approach can be used also if the analysis is conducted in different chromosomes 452 separately (for more details see Supplementary Note (d) ). repeatedly simulated data sets comprising 1,000 ("1k"), 5,000 ("5k"), 10,000 ("10k") and 463 20,000 (20k") individuals, respectively, totaling 500 replications for 20k and 1,000 464 replications for all other each sample sizes. Each data set was partitioned into "cases" and 465 "controls" of equal size by random assignment. We then derived empirical thresholds for 466 genome-wide significance by applying GECS under a threshold corresponding to minor 467 allele frequencies of MAF T = 0.01, 0.03 and 0.05, respectively. For comparison, COLL was 468 applied to single-marker analysis (SMA) without imposing a frequency threshold and results 469 were compared to those of GECS, delivering a base-line comparison for the performance of 470 our method. Note that under COLL, the SMA analysis is equivalent to the genotypic χ 2 test 471 under the dominant model. The global 5% significance threshold for each combination of 472 and sample size was estimated by the average 95% quantile for the test statistic across all 473 replications. 474
GECS power and performance study 475
Power assessment. In order to assess the power of GECS, we simulated autosomal local 476 DNA sequences (2.5-100kb) under different disease models in a case-control study design. 477
Simulating locally is justified by the expectation that true association signals will be small 478 compared to whole chromosomes. Since GECS is guaranteed to find all distinct subsequences, 479 we do not need to simulate association signals within whole genomes. Instead, we applied the 480 exhaustive scan for association on the simulated subsequences and used the sample-size and 481 variant-frequency specific genome-wide significance thresholds. Again, we also performed 482 single-marker association (SMA) tests for comparison. More specifically, we repeatedly 483 (Table S1 ). Furthermore, we considered sample sizes of 1000, 10,000, and 500 20,000 individuals. We restricted our analysis to variants with MAF T ≤ 0.01, corresponding to 501 equaling 19, 199 and 398 for the three sample sizes, respectively. For most combination of 502 parameters and sample sizes, 100 simulations were performed and GECS as well as a SMA 503 test were applied to test for phenotypic association (see Table S1 for more details). Obtained 504 nominal p-values were compared against simulation-based sample-size and frequency-specific 505 global significance thresholds. 506
Feasibility of GECS. We benchmarked GECS with respect to (i) the average reduction rate, 507 defined as ratio of the numbers of actually calculated bins to those theoretically existing with 508 a given set of variants, and (ii) the computational memory and time requirements. Since the 509 number of variants included in the analyses depended on the applied MAF T (MAF T =0.5 for 510 SMA; MAF T =0.01, 0.03, 0.05, respectively, for GECS), it is useful to consider the number of 511 performed tests for association in each study. The computation was conducted on Cheops, a 512 high-performance cluster of University of Cologne, Germany (https://rrzk.uni-513 koeln.de/cheops.html). Nodes used for the calculations possess 24 GB RAM and CPUs with 514 2.66 GHz. 515
Real-world data set analysis 516 We applied GECS to two previously analyzed data sets using three different MAF thresholds 517 and corrected for multiple testing using the combined significance thresholds. For each 518 corrected p-value, in the results of the analysis of AAMD and SCZD data, the upper and 519 lower limits of Wilson score binomial interval were calculated for 95% confidence interval. 520
Subsequently we performed an in-depth analysis of the significant regions ( Figure S2 ). The 521 in-depth analysis was performed locally using SKAT (WU et al. 2011), as implemented in the 522 SKAT R package (v 1.3.2.1), in two stages, the first of which was a locally exhaustive SKAT 523 ("eSKAT") with adjustment for age, sex and the first 10 principal components (p*-values). 524 SKAT uses single-SNP score test statistics and a default weighting scheme based on the 525 family of Beta(x, α, β) ~ x α-1 (1-x) β-1 distributions which assigns significantly higher weights to 526 variants with low MAFs. In addition, candidate regions with p*-values that indicated possible 527 association were re-analyzed with SKAT and common variants in physical proximity as 528 additional covariates (p'-values). The last step was performed to assure that the association in 529 the candidate region could not be explained simply due to linkage disequilibrium with an 530 associated, common variant. 531 European samples from this study and restricted the phenotype to AAMD cases (Table S2 -3). 552 GECS was applied with three MAF thresholds, namely 0.01, 0.03 and 0.05, for defining rare 553 variants. The final analysis was conducted by combining the results from all three thresholds 554 and applying correction for multiple testing (see Methods). In a post-GECS analysis, we 555 categorized all significant bins in blocks constituted by all overlapped bins in a region. Then 556 we determined bins with the lowest p-values in each block, each of them being defined by 557 their chromosomal positions and threshold MAF T . Subsequently, these bins were subject to 558 further locally exhaustive association analysis. 559
Schizophrenia Exome Study 560
Schizophrenia is a chronic debilitating mental disorder with a lifetime risk of about 0.7% and 561 a heritability of 60-80% conferred by common and rare alleles at many loci ( We analyzed WES variant data of 12,380 samples from the schizophrenia and bipolar disorder 578
Swedish case-control cohort (data deposited in dbGaP database under dbGaP accession: 579 phs000473.v2.p2). We included only those 10,898 samples that passed our quality control 580 regarding population stratification (Table S5) Tables   759   Table 1 : Empirical, sample-size dependent significance thresholds (α, with control of the 760 FWER at 5%) for simulated genome-wide studies. 1,000 1,000 2.95×10 -8 7.35×10 -10 3.61×10 -9 1.73×10 -9 1.60×10 -9 5,000 1,000 1.86×10 -8 3.31×10 -10 1.26×10 -9 8.92×10 -10 8.49×10 -10 10,000 1,000 1.27×10 -8 2.81×10 -10 1.05×10 -9 7.13×10 -10 6.91×10 -10 20,000 500 1.15×10 -8 2.59×10 -10 9.28×10 -10 6.36×10 -10 6.01×10 -10 763 764 765 
